Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 24.0B | 19.8B | 20.4B | 20.9B |
Cost of revenue | 10.9B | 8.7B | 4.0B | 9.3B |
Gross profit | 13.0B | 11.1B | 16.4B | 11.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 8.6B | 6.9B | 11.9B | 7.0B |
Operating income | 1.4B | 1.0B | 1.4B | 1.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.1B | 1.1B | 1.2B | 1.1B |
Other income expense | — | — | — | — |
Pretax income | 461.5M | 1.9B | 344.9M | 475.4M |
Tax provision | 213.3M | 78.7M | 91.7M | 128M |
Net income | 256.5M | 1.8B | 257.7M | 365.7M |
Basic EPS | — | 7.6 | 1.1 | 1.6 |
Diluted EPS | — | 7.6 | 1.1 | 1.6 |
Basic average shares | — | 239.3M | 229.5M | 228.0M |
Diluted average shares | — | 239.3M | 229.5M | 228.0M |
EBITDA | 3.3B | 2.9B | 3.2B | 3.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | 17.6M | 800K | -700K | 5.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |